Not only the etiology of chronic liver disease, tumor burden, renal function, severity of cirrhosis, and treatment modality, we also incorporated baseline performance status to generate adjusted hazard ratios of these two AFP cutoff values which could quantify the prognostic power of AFP. The gene discussed is AFP; the disease is neoplasm.